ArticleTranslational lung cancer research2024

Consolidation osimertinib for unresectable stage III epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer: redefining standard care.

Fang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.